Series A - Spear Bio

Series A - Spear Bio

Investment Firm

Overview

Spear Bio is a biotech company that focuses on the detection of ultrasensitive protein.

Announced Date

Jul 29, 2024

Closed on Date

Jul 29, 2024

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Foresite Capital

Foresite Capital

Foresite Capital is a early_stage_venture and late_stage_venture and post_ipo and private_equity and venture firm.

Bio-Techne

Bio-Techne

No designation

Participant Investors

5

Investor Name
Participant InvestorYonghua Capital
Participant InvestorCDH Investments
Participant InvestorBio-Techne
Participant InvestorForesite Capital
Participant InvestorMaverick Ventures

Round Details and Background

Spear Bio raised $45000000 on 2024-07-29 in Series A

Spear Bio is a biotech company that focuses on the detection of ultrasensitive protein.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 13, 2023
Seed Round - Spear Bio
4-undefined
Jul 29, 2024
Series A - Spear Bio
5-45.0M

Recent Activity

There is no recent news or activity for this profile.